These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 27572810)

  • 1. MRI-CEST assessment of tumour perfusion using X-ray iodinated agents: comparison with a conventional Gd-based agent.
    Anemone A; Consolino L; Longo DL
    Eur Radiol; 2017 May; 27(5):2170-2179. PubMed ID: 27572810
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In Vitro and In Vivo Assessment of Nonionic Iodinated Radiographic Molecules as Chemical Exchange Saturation Transfer Magnetic Resonance Imaging Tumor Perfusion Agents.
    Longo DL; Michelotti F; Consolino L; Bardini P; Digilio G; Xiao G; Sun PZ; Aime S
    Invest Radiol; 2016 Mar; 51(3):155-62. PubMed ID: 26460826
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The interaction between iodinated X-ray contrast agents and macrocyclic GBCAs provides a signal enhancement in T
    Di Gregorio E; Arena F; Gianolio E; Ferrauto G; Aime S
    Magn Reson Med; 2022 Jul; 88(1):357-364. PubMed ID: 35253921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dual assessment of kidney perfusion and pH by exploiting a dynamic CEST-MRI approach in an acute kidney ischemia-reperfusion injury murine model.
    Irrera P; Consolino L; Cutrin JC; Zöllner FG; Longo DL
    NMR Biomed; 2020 Jun; 33(6):e4287. PubMed ID: 32153058
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investigating plasma volume expanders as novel macromolecular MRI-CEST contrast agents for tumor contrast-enhanced imaging.
    Consolino L; Irrera P; Romdhane F; Anemone A; Longo DL
    Magn Reson Med; 2021 Aug; 86(2):995-1007. PubMed ID: 33764575
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of cerebral perfusion by first-pass, dynamic, contrast-enhanced, steady-state free-precession MR imaging: an animal study.
    Runge VM; Kirsch JE; Wells JW; Woolfolk CE
    AJR Am J Roentgenol; 1993 Mar; 160(3):593-600. PubMed ID: 8430562
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of iopromide and iopamidol, two acidoCEST MRI contrast media that measure tumor extracellular pH.
    Moon BF; Jones KM; Chen LQ; Liu P; Randtke EA; Howison CM; Pagel MD
    Contrast Media Mol Imaging; 2015; 10(6):446-55. PubMed ID: 26108564
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MRI evaluation of "solitary" brain metastases with triple-dose gadoteridol: comparison with contrast-enhanced CT and conventional-dose gadopentetate dimeglumine MRI studies in the same patients.
    Kuhn MJ; Hammer GM; Swenson LC; Youssef HT; Gleason TJ
    Comput Med Imaging Graph; 1994; 18(5):391-9. PubMed ID: 7954317
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Using two chemical exchange saturation transfer magnetic resonance imaging contrast agents for molecular imaging studies.
    Ali MM; Liu G; Shah T; Flask CA; Pagel MD
    Acc Chem Res; 2009 Jul; 42(7):915-24. PubMed ID: 19514717
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potential for differentiation of pseudoprogression from true tumor progression with dynamic susceptibility-weighted contrast-enhanced magnetic resonance imaging using ferumoxytol vs. gadoteridol: a pilot study.
    Gahramanov S; Raslan AM; Muldoon LL; Hamilton BE; Rooney WD; Varallyay CG; Njus JM; Haluska M; Neuwelt EA
    Int J Radiat Oncol Biol Phys; 2011 Feb; 79(2):514-23. PubMed ID: 20395065
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative analysis of ferumoxytol and gadoteridol enhancement using T1- and T2-weighted MRI in neuroimaging.
    Hamilton BE; Nesbit GM; Dosa E; Gahramanov S; Rooney B; Nesbit EG; Raines J; Neuwelt EA
    AJR Am J Roentgenol; 2011 Oct; 197(4):981-8. PubMed ID: 21940589
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Flip-angle based ratiometric approach for pulsed CEST-MRI pH imaging.
    Arena F; Irrera P; Consolino L; Colombo Serra S; Zaiss M; Longo DL
    J Magn Reson; 2018 Feb; 287():1-9. PubMed ID: 29272735
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Measuring in vivo tumor pHe with CEST-FISP MRI.
    Sheth VR; Li Y; Chen LQ; Howison CM; Flask CA; Pagel MD
    Magn Reson Med; 2012 Mar; 67(3):760-8. PubMed ID: 22028287
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of tamoxifen in an experimental model of breast tumor studied by dynamic contrast-enhanced magnetic resonance imaging and different contrast agents.
    Marzola P; Ramponi S; Nicolato E; Lovati E; Sandri M; Calderan L; Crescimanno C; Merigo F; Sbarbati A; Grotti A; Vultaggio S; Cavagna F; Lorusso V; Osculati F
    Invest Radiol; 2005 Jul; 40(7):421-9. PubMed ID: 15973133
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A new contrast in MR mammography by means of chemical exchange saturation transfer (CEST) imaging at 3 Tesla: preliminary results.
    Schmitt B; Zamecnik P; Zaiss M; Rerich E; Schuster L; Bachert P; Schlemmer HP
    Rofo; 2011 Nov; 183(11):1030-6. PubMed ID: 22034086
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dynamic gadoteridol-enhanced MR imaging in the end of growing long bone of piglets.
    Li XM; Xiong W; Hu DY; Yu C; Peng WJ; Hu JW; Feng DY; Hu XM; Li HL; Qiu L; Li F
    Chin Med J (Engl); 2008 Oct; 121(19):1932-8. PubMed ID: 19080127
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Consecutive acquisition of time-resolved contrast-enhanced MR angiography and perfusion MR imaging with added dose of gadolinium-based contrast agent aids diagnosis of suspected brain metastasis.
    Tsuchiya K; Aoki S; Shimoji K; Mori H; Kunimatsu A
    Magn Reson Med Sci; 2013; 12(2):87-93. PubMed ID: 23666159
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative comparison of delayed ferumoxytol T
    Horváth A; Varallyay CG; Schwartz D; Toth GB; Netto JP; Barajas R; Várallyay P; Szidonya L; Firkins J; Youngers E; Fu R; Ambady P; Bogner P; Neuwelt EA
    Magn Reson Med; 2018 Jul; 80(1):224-230. PubMed ID: 29205477
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intra-individual, randomised comparison of the MRI contrast agents gadobutrol versus gadoteridol in patients with primary and secondary brain tumours, evaluated in a blinded read.
    Koenig M; Schulte-Altedorneburg G; Piontek M; Hentsch A; Spangenberg P; Schwenke C; Harders A; Heuser L
    Eur Radiol; 2013 Dec; 23(12):3287-95. PubMed ID: 23824152
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Magnetic resonance imaging of intracranial tumors: intra-patient comparison of gadoteridol and ferumoxytol.
    Dósa E; Guillaume DJ; Haluska M; Lacy CA; Hamilton BE; Njus JM; Rooney WD; Kraemer DF; Muldoon LL; Neuwelt EA
    Neuro Oncol; 2011 Feb; 13(2):251-60. PubMed ID: 21163809
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.